Latest News

ECTRIMS 2015

 

Dr. Marcelo Kremenchutzky, Director of the Multiple Sclerosis clinic at the London Health Sciences Centre, interviews researchers at the annual meeting of the European Committee for Treatment and Research in MS (ECTRIMS).

Read More

1 dead in phase I trial

 

One person is dead and five others are hospitalized in a phase I trial that went badly wrong. Three of the survivors may have suffered irreversible brain damage, according to Dr. Gilles Edan, head of neurology at the Centre Hospitalier Universitaire de Rennes, France, as quoted in the New York Times (Chanjan S. NY Times, Jan. 15, 2016). Preliminary MRI results showed cerebral hemorrhage and brain necrosis in some study participants. Read More